The observed levels of IL-23 and I-309 (also known as CCL1) in this study on treatment with free Doc in LNCaP cells correspond with their established pro-inflammatory roles and their role in promoting tumor growth and proliferation [78,79]. This evidence concerns the gene CCL1 and neoplasm.